eBook Chapter 2 - Tumour Biology Flashcards
1
Q
What are the 4 properties of a malignant cell?
A
- detachment from primary mass
- invasion of ECM e.g. basement membrane
- adhesion to endothelium and extravasation
- colonisation of and survival in secondary organ
2
Q
Malignant is associated with the loss of what 4 processes?
A
- density dependent inhibition of growth
- contract inhibition of movement
- anchorage dependence
- adhesion
3
Q
What are the 6 steps of the metastatic cascade?
A
- Detachment from the primary tumour mass (which requires reorganisation of the cell-cell and cell-matrix adhesion complexes)
- Invasion through the basement membrane into adjacent stroma (which requires secretion of MMPs, restructuring the ECM and migration of the cells)
- Intravasation into the blood vessels (this requires interaction of cancer cells with endothelium
- survival of cancerous cell sin blood stream and avoidance of the immune system
- extravasation through integration with the endothelial lining inside vessels (and interaction with selectins and integrins)
- establishment of micro-metastases at the secondary site
4
Q
Describe EMT and its transcription factors
A
Epithelial Mesenchymal Transition
- program that regulates invasion and metastasis
- physiologically, it is implicated in various stages of embryonic development and wound healing
- tumour epithelial cells switch to EMT to increase their mobility allowing them to invade and metastasise
- EMT is a reversible process and is governed by transcription factors including Snail, Slug, Twist and Zeb1/2.
5
Q
Describe normal adhesion
How it is loss in cancer
The consequences for its loss
(Next flashcard details E-cadherin loss)
A
- normally, epithelial cells are helps together by adhesion complexes
- there are 3 types of complexes that support cells: tight junctions, adheres junctions and desmosomes
- adhesion molecules of the cadherin family are the main adhesion receptors in adherens junctions and desmosomes, tight junctions are controlled by junctional adhesion molecules (JAMS)
- adhesion receptors are down regulated in metastatic cancer cells
- in particular, downregulation of E-cadherin is common via inactivating mutations, epigenetic silencing, proteolytic cleavage and proteosomal degredation. Additionaly E-cadherin loss cold be part of EMT
6
Q
Describe in detail the loss of E-cadherin
A
- E-cadherin is anchored to actin filament of cytoskeleton by alpha and beta-catenins
- if free beta-catenin accumulates in the cytoplasm it is phosphorylated in combination with the APC protein and is degrading in the proteasome.
- beta-catenin is also a key player in Wnt signalling pathway
- when APC gene is mutated, beta-catenin accumulates in cuytoplasm, migrates to the nucleus and associates with Tcf/LEF and other TFs thus activating EMT programme
7
Q
Describe tissue invasion
A
- invasion of tissues requires matrix metalloproteinases (MMPs), secreted by stromal and tumour cells, degrade ECM and allow the malignant cell to invades and move by amoeboid of mesenchymal movement
8
Q
Describe hypoxia and its consequences
A
- cells in the middle of the tumour mass become hypoxic as the diffusion limit for oxygen is about 100um
- cells growing away from the source of oxygen undergo selection and only those able to adapt sivirve
- hypoxia drives changes in metabolism and induces tumour angiogenesis
- cancer cels can reprogram their glucose metabolise, even in the presence of oxygen, if it gives them a growth advances over normal cells, this is called the glyolytic switch and involves the upregulation of glycolysis
- HIFs are the major players in the initiation of the glycolytic switch
- in hypoxic condition, HIFs accumulate and are transported t the nucleus where they bind to hypoxia responsive elements and induce transcription of glycolysis enzymes (e.g. GLUT1) and angiogenesis genes (e.g. VEGF, Ang2, NOS, PDGF-B0)
- thus hypoxia induces angiogenesis so tumours undergo the angiogenic switch, secreting factors that cause continous sportuong of the normally quiescent vasculature
- there are different mechanism of tumour vascularisation including, recruitment of EPCs, insuscetive angiongeneic, sprouting angiotensin, vasculogenic mimicry, vessel co-option
- the newly formed vessels in tumours are immature, branched and distorted with an uneven diameter. this leads to erratic blood flow and leakiness
- the site of metastasis are determined by many factors and even cells that do metastasise do not necessarily survive and colonise the secondary tissue. metastasis is very inefficient